Kathy Turner V - 31 Aug 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Issuer symbol
IDXX
Transactions as of
31 Aug 2021
Net transactions value
+$99,902
Form type
4
Filing time
02 Sep 2021, 17:03:57 UTC
Previous filing
31 Aug 2021
Next filing
16 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99,902 +1,256 +44% $79.54* 4,131 31 Aug 2021 Direct
holding IDXX Common Stock 100 31 Aug 2021 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1,256 -100% 0 31 Aug 2021 Common Stock 1,256 $79.54 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 628 shares on February 14, 2020, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3 Not applicable.